U.S. markets close in 6 hours 3 minutes

Fusion Pharmaceuticals Inc. (FUSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.81-0.05 (-0.62%)
As of 9:55AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/20/2021
Current
6/30/20213/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
386.32M343.05M448.58M490.28M500.80M727.87M
Enterprise Value 3
215.14M123.35M226.18M198.33M181.91M660.45M
Trailing P/E
0.42N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
724.47N/AN/AN/AN/AN/A
Price/Book (mrq)
1.471.231.521.601.5912.48
Enterprise Value/Revenue 3
412.94236.75N/AN/AN/AN/A
Enterprise Value/EBITDA 7
-3.24-4.55-12.87-17.05-17.88-92.20

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-27.67%
S&P500 52-Week Change 335.39%
52 Week High 313.89
52 Week Low 36.61
50-Day Moving Average 38.64
200-Day Moving Average 38.87

Share Statistics

Avg Vol (3 month) 341.48k
Avg Vol (10 day) 392.76k
Shares Outstanding 543.02M
Implied Shares Outstanding 6N/A
Float 22.9M
% Held by Insiders 18.96%
% Held by Institutions 179.12%
Shares Short (Aug 30, 2021) 4132.5k
Short Ratio (Aug 30, 2021) 43.27
Short % of Float (Aug 30, 2021) 40.31%
Short % of Shares Outstanding (Aug 30, 2021) 40.31%
Shares Short (prior month Jul 29, 2021) 4179.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-12,833.97%

Management Effectiveness

Return on Assets (ttm)-13.81%
Return on Equity (ttm)-23.42%

Income Statement

Revenue (ttm)521k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -66.39M
Net Income Avi to Common (ttm)-67.76M
Diluted EPS (ttm)-1.61
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)178.52M
Total Cash Per Share (mrq)4.15
Total Debt (mrq)7.34M
Total Debt/Equity (mrq)2.79
Current Ratio (mrq)19.77
Book Value Per Share (mrq)6.18

Cash Flow Statement

Operating Cash Flow (ttm)-53.85M
Levered Free Cash Flow (ttm)-41.31M